Faculty profile

Padraig Warde

Back to faculty

ProfessorDepartment of Radiation OncologyUniversity of Toronto

Padraig Warde

Professor

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
16 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

3,978

Citations

139

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.
The Journal of urology · 2026
Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.
Urologic oncology · 2026
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.
International journal of radiation oncology, biology, physics · 2026

All 85 publications

Latest funding

TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer: a pilot RCT and process evaluation (TOPCOP3)
CIHR · 2022 · Co-investigator
$100,000
Benchmarking the quality of urologic cancer care in Ontario: a population-based analysis
CIHR · 2016 · Co-investigator
$96,250
Advancing Personalized Cancer Care with an Automated Radiomics-Based Radiation Therapy Method
CIHR · 2016 · Co-investigator
$276,283

All 7 grants and awards

85 publications.

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.

Mousa A, Chavarriaga J, Kaushal S, Burrafato Z, Anson-Cartwright L, Atenafu EG, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Jewett MAS, Hamilton RJ

The Journal of urology2026

DOI: 10.1097/ju.0000000000004847 PMID: 41212998

Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.

Mousa A, Hayes J, Amiri A, Anson-Cartwright L, Atenafu EG, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Hamilton RJ

Urologic oncology2026

DOI: 10.1016/j.urolonc.2026.111082 PMID: 41934019

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

Glicksman RM, Winter J, McPartlin A, Santiago AT, Wang K, Bernstein J, Dang J, Tsui G, Chung P, Mesci A, Gutierrez Valencia E, Raman S, Berlin A, Catton C, Bayley A, Warde P, Krishna S, Finelli A, Hamilton RJ, Pace KT, Kitchlu A, Helou J

International journal of radiation oncology, biology, physics2026Open Access

DOI: 10.1016/j.ijrobp.2025.11.005 PMID: 41290048

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Mathew JM, Bacon H, Winter J, Bernstein J, Liu ZA, Kong V, Dang J, Wang K, Chung P, Bayley A, Berlin A, Catton C, Gutierrez E, Mesci A, McPartlin A, Raman S, Alibhai S, Taylor E, Warde P, Glicksman RM

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111614 PMID: 42177994

Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?

Rachel Glicksman, Di Maria Jiang, Philippe Lucien Bedard, Xiang Y. Ye, Lynn Anson‐Cartwright, Astrid Billfalk-Kelly, Satheesh Krishna, Martin O’Malley, Carol CY Cheung, Abigail Shin, Robert James Hamilton, Padraig Richard Warde, Peter W M Chung

International Journal of Radiation Oncology*Biology*Physics20252 citationsOpen Access

DOI: 10.1016/j.ijrobp.2024.12.022 PMID: 39778682

Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.

Mousa A, Anson-Cartwright L, Atenafu EG, Jewett MAS, Bedard P, Jiang DM, Glicksman R, Chung P, Warde P, O'Malley M, Prendeville S, Hamilton RJ

BJU international20247 citationsOpen Access

DOI: 10.1111/bju.16448 PMID: 38967557

A feasibility study of adaptive radiation therapy for postprostatectomy prostate cancer.

Meyers SM, Winter JD, Obeidi Y, Chung P, Menard C, Warde P, Fong H, McPartlin A, Parameswaran S, Berlin A, Bayley A, Catton C, Craig T

Medical dosimetry : official journal of the American Association of Medical Dosimetrists20242 citationsOpen Access

DOI: 10.1016/j.meddos.2023.10.008 PMID: 37985297

Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy.

Magee DE, Cheung DC, Hird AE, Chung P, Warde P, Catton C, Berlin A, Zlotta A, Fleshner NE, Kulkarni GS

Urology practice20235 citations

DOI: 10.1097/upj.0000000000000403 PMID: 37103562

Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.

Sanmamed N, Joseph L, Crook J, Craig T, Warde P, Tomasso AD, Chung P, Berlin A, Bayley A, Saibishkumar EP, Glicksman R, Raman S, Catton C, Helou J

Brachytherapy20232 citations

DOI: 10.1016/j.brachy.2022.09.159 PMID: 36549968

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic

Walker MJ, Wang J, Mazuryk J, Skinner S-M, Meggetto O, Ashu E, Habbous S, Nazeri Rad N, Espino-Hernández G, Wood R

JAMA Network Open202288 citationsOpen Access

DOI: 10.1001/jamanetworkopen.2022.8855

TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer: a pilot RCT and process evaluation (TOPCOP3)

Co-investigatorCIHR2022Project Grant - Priority Announcement: Patient-Oriented Research

Principal investigators: Alibhai, Shabbir M; Emmenegger, Urban; Puts, Maria (Martine) T

Keywords: Factorial Design; Feasibility; Geriatric Assessment; Geriatric Oncology; Hormone Therapies; Prostate Cancer; Quality Of Life; Randomized Controlled Trial; Treatment Toxicity

$100,000

Benchmarking the quality of urologic cancer care in Ontario: a population-based analysis

Co-investigatorCIHR2016Catalyst Grant: Health Services and Economics Research in Cancer Control

Principal investigators: Finelli, Antonio

Keywords: Benchmarking; Kidney; Prostate; Quality Improvement; Quality Indicators; Urologic Oncology

$96,250

Advancing Personalized Cancer Care with an Automated Radiomics-Based Radiation Therapy Method

Co-investigatorCIHR2016Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Purdie, Thomas G; Chan, Timothy; Ward, Aaron

Keywords: 1101 Human Health; 1211 Medical And Health Sciences; 2603 Computer Vision; 2715 Optimization; Automation; Knowledge-Based Radiation Treatment Planning; Medical Image Analysis; Medical Physics; Personalized Cancer Medicine; Radiation Oncology

$276,283

An RCT and economic analysis of three exercise delivery methods in men with prostate cancer on ADT

Co-investigatorCIHR2013Operating Grant

Principal investigators: Alibhai, Shabbir M

Keywords: Androgen Deprivation Therapy; Bone Mineral Density; Cancer-Related Fatigue; Cost-Effectiveness; Elderly; Exercise; Physical Fitness; Prostate Cancer; Quality Of Life; Randomized Controlled Trial

$781,091

Improving Quality and Patient Safety in Radiation Therapy by Integrating Multi-Disciplinary Criteria into an Artificial Intelligence System

Co-investigatorCIHR2012Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Purdie, Thomas G; Jurisica, Igor

Keywords: 1211 Medical And Health Sciences; 2603 Computer Vision; 2605 Pattern Analysis And Machine Intelligence; 2804 Expert Systems; 9000 Health Sciences; Automation; Medical Physics; Patient Safety; Quality Assurance; Radiation Oncology

$325,530

A randomized trial of a shorter radiation fraction schedule for the treatment of localised prostate cancer

Co-investigatorCIHR2010Operating Grant

Principal investigators: Levine, Mark N; Catton, Charles N; Lukka, Himanshu R

Keywords: Biochemical Clinical Failure; Dose Escalation; Hypofractionation; Prostate Cancer; Radiotherapy; Randomized Trial

$300,236

Transition to Survivorship: Translating knowledge into action for testicular and endometrial cancer populations.

Co-investigatorCIHR2010Operating Grant

Principal investigators: Jones, Jennifer M; Howell, Doris M

Keywords: Cancer Survivorship; Integrated Knowledge Translation; Participatory Research Methods

$256,582

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Padraig Warde

Research

Latest papers

Latest funding

Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors.

Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?

Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy.

A feasibility study of adaptive radiation therapy for postprostatectomy prostate cancer.

Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy.

Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic

TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer: a pilot RCT and process evaluation (TOPCOP3)

Benchmarking the quality of urologic cancer care in Ontario: a population-based analysis

Advancing Personalized Cancer Care with an Automated Radiomics-Based Radiation Therapy Method

An RCT and economic analysis of three exercise delivery methods in men with prostate cancer on ADT

Improving Quality and Patient Safety in Radiation Therapy by Integrating Multi-Disciplinary Criteria into an Artificial Intelligence System

A randomized trial of a shorter radiation fraction schedule for the treatment of localised prostate cancer

Transition to Survivorship: Translating knowledge into action for testicular and endometrial cancer populations.

Frequent collaborators

Peter Chung

Charles Catton

Andrew Bayley

Alejandro Berlin

Mary Gospodarowicz

Philippe Bedard

Neil Fleshner

Shabbir Alibhai

Michael Milosevic

Martin O'Malley

Tara Rosewall

George Tomlinson

Joan Sweet

Rachel Glicksman

Bernard Cummings

Murray Krahn

Fei-Fei Liu

Tony Panzarella

Alexandre Zlotta

Antonio Finelli

John Waldron

David Jaffray

Ur Metser

Jolie Ringash

Brian O'Sullivan

David Payne

Patrick Gullane

Ants Toi

I. Naglie

Andrew McPartlin

Barbara-Ann Millar

Ian Tannock

Winnie Li

Aruz Mesci

Eric Leung

Jean-Paul Bahary

John Trachtenberg

Jeremy Freeman

Ralph Gilbert

Raj Satkunasivam